The consistent SIRT1 cellular expression pattern, identified in our malignant tumor samples and characterized by relative loss and cytoplasmic shift, allows us to hypothesize that SIRT1 may be a tumor modulator and may even play an onco-suppressive role in canine mammary tumors. The gene discussed is SIRT1; the disease is breast cancer.